Table of Contents Author Guidelines Submit a Manuscript
Sarcoma
Volume 2011, Article ID 834170, 5 pages
http://dx.doi.org/10.1155/2011/834170
Research Article

Impairment of Methotrexate Transport Is Common in Osteosarcoma Tumor Samples

1Division of Hematology/Oncology, Department of Pediatrics, The Children's Hospital at Montefiore, The Albert Einstein College of Medicine of Yeshiva University, 3415 Bainbridge Avenue, Rosenthal Rm 300, Bronx, NY 10467, USA
2Department of Pediatrics, Memorial Sloan-Kettering Cancer Center New York, NY 10065, USA
3c/o Veterans Administration New York Harbor Healthcare System, Narrows Institute for Biomedical Research Brooklyn, NY 11209, USA
4Charlotte Kimelman Cancer Institute, 9048 Sugar Estate, St. Thomas USVI 00802, British Virgin Islands
5Division of Orthopaedic Surgery, Department of Surgery, Memorial Sloan-Kettering Cancer Center New York, NY 10065, USA

Received 13 September 2010; Accepted 15 November 2010

Academic Editor: Stephen Lessnick

Copyright © 2011 Rebecca Sowers et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [15 citations]

The following is the list of published articles that have cited the current article.

  • Sheref E. Hassan, Mikhail Bekarev, Mimi Y. Kim, Juan Lin, Sajida Piperdi, Richard Gorlick, and David S. Geller, “Cell surface receptor expression patterns in osteosarcoma,” Cancer, vol. 118, no. 3, pp. 740–749, 2011. View at Publisher · View at Google Scholar
  • J. H. Healey, “Le nuove frontiere della ricerca in oncologia del sistema muscolo-scheletrico,” LO SCALPELLO-OTODI Educational, vol. 25, no. 3, pp. 173–181, 2011. View at Publisher · View at Google Scholar
  • Jason A. Sprowl, Torben S. Mikkelsen, Hugh Giovinazzo, and Alex Sparreboom, “Contribution of tumoral and host solute carriers to clinical drug response,” Drug Resistance Updates, vol. 15, no. 1-2, pp. 5–20, 2012. View at Publisher · View at Google Scholar
  • Fabian Mairinger, Claudia Vollbrecht, Iris Halbwedl, Martina Hatz, Elvira Stacher, Christian Gülly, Franz Quehenberger, Susann Stephan-Falkenau, Jens Kollmeier, Andreas Roth, Thomas Mairinger, and Helmut Popper, “Reduced Folate Carrier and Folylpolyglutamate Synthetase, but not Thymidylate Synthase Predict Survival in Pemetrexed-Treated Patients Suffering from Malignant Pleural Mesothelioma,” Journal of Thoracic Oncology, pp. 1, 2013. View at Publisher · View at Google Scholar
  • Michael Roth, Marissa Linkowski, John Tarim, Sajida Piperdi, Rebecca Sowers, David Geller, Jonathan Gill, and Richard Gorlick, “Ganglioside GD2 as a therapeutic target for antibody-mediated therapy in patients with osteosarcoma,” Cancer, 2013. View at Publisher · View at Google Scholar
  • Jonathan Gill, Manpreet K. Ahluwalia, David Geller, and Richard Gorlick, “New targets and approaches in osteosarcoma,” Pharmacology & Therapeutics, vol. 137, no. 1, pp. 89–99, 2013. View at Publisher · View at Google Scholar
  • Jian-Jun Wang, Hong Lu, Yuan-Jue Sun, and Yang Yao, “The correlation between the expression of drug resistance gene and the recurrence of osteosarcoma,” Tumor, vol. 34, no. 9, pp. 838–849, 2014. View at Publisher · View at Google Scholar
  • Jason A. Sprowl, “Uptake Carriers and Oncology Drug Safety,” Drug Metabolism and Disposition, vol. 42, no. 4, pp. 611–622, 2014. View at Publisher · View at Google Scholar
  • Michael Roth, David M. Barris, Sajida Piperdi, Vicky Kuo, Stephanie Everts, David Geller, Peter Houghton, E. Anders Kolb, Thomas Hawthorne, Jonathan Gill, and Richard Gorlick, “Targeting glycoprotein NMB with antibody-drug conjugate, glembatumumab vedotin, for the treatment of osteosarcoma,” Pediatric Blood & Cancer, 2015. View at Publisher · View at Google Scholar
  • David S. Geller, Michael Y. Singh, Wendong Zhang, Jonathan Gill, Michael E. Roth, Mimi Y. Kim, Xianhong Xie, Christopher K. Singh, Howard D. Dorfman, Esperanza Villanueva-Siles, Amy Park, Sajida Piperdi, and Richard Gorlick, “Development of a Model System to Evaluate Local Recurrence in Osteosarcoma and Assessment of the Effects of Bone Morphogenetic Protein-2,” Clinical Cancer Research, vol. 21, no. 13, pp. 3003–3012, 2015. View at Publisher · View at Google Scholar
  • Marcella Laschi, Giulia Bernardini, Michela Geminiani, Lorenzo Ghezzi, Loredana Amato, Daniela Braconi, Lia Millucci, Bruno Frediani, Adriano Spreafico, Alessandro Franchi, Domenico Campanacci, Rodolfo Capanna, and Annalisa Santucci, “Establishment of Four New Human Primary Cell Cultures from Chemo-Naïve Italian Osteosarcoma Patients,” Journal of Cellular Physiology, vol. 230, no. 11, pp. 2718–2727, 2015. View at Publisher · View at Google Scholar
  • Laura Taddia, Domenico D’Arca, Stefania Ferrari, Chiara Marraccini, Leda Severi, Glauco Ponterini, Yahuda G. Assaraf, Gaetano Marverti, and Maria Paola Costi, “Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: novel strategies to overcome cancer chemoresistance,” Drug Resistance Updates, 2015. View at Publisher · View at Google Scholar
  • Murray D. Norris, Dilafruz Juraeva, Diana T. Lau, Glenn M. Marshall, Michelle Haber, Jamie I. Fletcher, Lesley J. Ashton, Claudia L. Flemming, Samuele Gherardi, Giovanni Perini, André Oberthuer, Matthias Fischer, Benedikt Brors, and Chengyuan Xue, “MYCN amplification confers enhanced folate dependence and methotrexate sensitivity in neuroblastoma,” Oncotarget, vol. 6, no. 17, pp. 15510–15523, 2015. View at Publisher · View at Google Scholar
  • Pratistha Koirala, Michael E. Roth, Jonathan Gill, Sajida Piperdi, Jordan M. Chinai, David S. Geller, Bang H. Hoang, Amy Park, Michael A. Fremed, Xingxing Zang, and Richard Gorlick, “Immune infiltration and PD-L1 expression in the tumor microenvironment are prognostic in osteosarcoma,” Scientific Reports, vol. 6, pp. 30093, 2016. View at Publisher · View at Google Scholar
  • Min Li, Bing He, Xiaojuan He, Guofen Chen, Baosheng Guo, Defang Li, Feng Jiang, Lei Dang, Shaowei Zheng, Chao Liang, Jin Liu, Cheng Lu, Biao Liu, Jun Lu, Luyao Wang, Aiping Lu, Ge Zhang, Atik Shaikh, and Fangfei Li, “Present Advances and Future Perspectives of Molecular Targeted Therapy for Osteosarcoma,” International Journal of Molecular Sciences, vol. 17, no. 4, pp. 506, 2016. View at Publisher · View at Google Scholar